Precigen, Inc. (PGEN)
Nasdaq · Healthcare
$7.74−9.37%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $2.8B
- 52-week range
- $2.99 – $8.98
- 52-week change
- +158.01%
- EPS (trailing)
- −$0.94
- Analyst rating
- 1.8 Buy
- Next earnings
- Nov 12, 2026
Fiscal year to Dec 2025
- Revenue
- $9.7M (+146.73%)
- Net income
- −$251M
- Operating margin
- −1141.2%
- Diluted EPS
- −$1.37
- Free cash flow
- −$89.8M
From the company’s annual report on SEC EDGAR.